{
    "sigir-20141": {
        "NCT01397994": {
            "relevance_explanation": "The clinical trial is focused on patients with chronic stable angina, a condition characterized by predictable and long-term chest pain. The patient presents with episodic chest pain that began two days ago, which does not align with chronic stable angina. However, the patient meets other general criteria such as age, gender, and willingness to comply with the study protocol.",
            "relevance_score_R": 50.0,
            "eligibility_explanation": "The patient does not meet the primary inclusion criterion of having chronic stable angina with specific ischemic changes, which is crucial for the trial. However, the patient meets other inclusion criteria such as age, gender, and willingness to comply. The patient is not excluded by any exclusion criteria, but there is insufficient information to confirm eligibility for some criteria, such as specific blood pressure readings and eligibility for Tc 99m SPECT.",
            "eligibility_score_E": 10.0
        },
        "NCT00149227": {
            "relevance_explanation": "The patient is relevant to the clinical trial as she has hypertension, which is a target condition of the trial. Additionally, she has obesity, a risk factor mentioned in the inclusion criteria, and nonspecific EKG changes, which could be relevant to the trial's focus on cardiovascular conditions.",
            "relevance_score_R": 85.0,
            "eligibility_explanation": "The patient meets the inclusion criteria as she has hypertension and obesity, which are risk factors. She is not excluded by any of the exclusion criteria, as she is not on ARBs, has no recent history of PCI or CABG, and there is no indication of severe hypertension or other exclusionary conditions. However, there is insufficient information regarding renal and hepatic function, which could potentially affect eligibility.",
            "eligibility_score_E": 75.0
        }
    },
    "sigir-20142": {
        "NCT02618655": {
            "relevance_explanation": "The clinical trial is focused on diagnosing tick-borne diseases in patients with unexplained acute fever. The patient is an 8-year-old male presenting with fever, dyspnea, and cough, which are relevant symptoms for the trial. However, the trial specifically targets patients with fever of unknown origin, and the patient's symptoms suggest a respiratory infection rather than a tick-borne disease. Additionally, the patient has only had a fever for 2 days, whereas the trial requires a fever duration of more than one week for inclusion.",
            "relevance_score_R": 50.0,
            "eligibility_explanation": "The patient meets one inclusion criterion (fever higher than 38\u00b0C) and is not excluded by any exclusion criteria. However, the patient does not meet the key inclusion criterion of having a fever for more than one week, which significantly impacts eligibility. The lack of information on a full examination after one week and the short duration of fever further limit eligibility.",
            "eligibility_score_E": 10.0
        },
        "NCT00711399": {
            "relevance_explanation": "The clinical trial is focused on respiratory sounds, and the patient presents with symptoms related to respiratory conditions, such as cough and dyspnea. The trial aims to evaluate respiratory symptoms, which aligns with the patient's current condition. Therefore, the patient is relevant to the trial.",
            "relevance_score_R": 85.0,
            "eligibility_explanation": "The patient meets the inclusion criteria by providing informed consent and having symptoms of cough and dyspnea. However, the patient is excluded due to being in respiratory distress, which is a specific exclusion criterion. This exclusion significantly impacts eligibility, resulting in the patient being ineligible for the trial.",
            "eligibility_score_E": -85.0
        }
    },
    "sigir-20143": {
        "NCT02490059": {
            "relevance_explanation": "The patient is a 58-year-old female with a left lung mass, which is relevant to the trial focusing on solitary pulmonary nodules (SPN) and lung cancer. The trial aims to evaluate diagnostic methods for SPNs, and the patient's condition aligns with the target condition of the trial. Additionally, the patient is willing to provide informed consent and comply with the trial protocol, which is relevant for participation.",
            "relevance_score_R": 85.0,
            "eligibility_explanation": "The patient meets the inclusion criteria as she has a lung mass, which is likely a pulmonary nodule, and there is no information suggesting it is visible on standard bronchoscopy. She is also not excluded by the exclusion criterion, as she will provide informed consent. Therefore, the patient is eligible for the trial.",
            "eligibility_score_E": 85.0
        },
        "NCT01452971": {
            "relevance_explanation": "The patient is highly relevant to the clinical trial as she has a left lung mass, which suggests lung cancer. The trial is focused on lung cancer patients and the interaction between GNMT and lung cancer, which aligns with the patient's condition.",
            "relevance_score_R": 90.0,
            "eligibility_explanation": "The patient is likely eligible for the trial. She is included based on the inclusion criterion of being a lung cancer patient, as inferred from the presence of a left lung mass. She is not excluded by any exclusion criteria, as she is over 18 years old and is inferred to be a lung cancer patient.",
            "eligibility_score_E": 90.0
        }
    },
    "sigir-20144": {
        "NCT02390596": {
            "relevance_explanation": "The patient is a 2-year-old boy with symptoms consistent with Kawasaki Disease, including fever for 5 days, conjunctivitis, strawberry tongue, inflammation of the hands and feet, desquamation, and cervical lymphadenopathy. The echocardiogram shows coronary artery dilation, which supports the diagnosis of incomplete KD. The trial is focused on Kawasaki Disease in children, making the patient highly relevant to the trial. However, there is no information about the patient's response to standard treatment, which is a key aspect of the trial.",
            "relevance_score_R": 85.0,
            "eligibility_explanation": "The patient meets several inclusion criteria: age and weight requirements, symptoms consistent with Kawasaki Disease, and informed consent. However, there is no information on whether the patient has failed to respond to standard therapy, which is a crucial inclusion criterion. The patient is not excluded by any exclusion criteria. The lack of information on the response to standard therapy significantly impacts eligibility.",
            "eligibility_score_E": 40.0
        },
        "NCT00841789": {
            "relevance_explanation": "The patient is a 2-year-old boy presenting with symptoms consistent with Kawasaki Disease, which is the target condition of the clinical trial. The trial is investigating the use of Etanercept in conjunction with IVIG and aspirin for Kawasaki Disease, making the patient highly relevant to the trial.",
            "relevance_score_R": 95.0,
            "eligibility_explanation": "The patient meets all inclusion criteria: he is within the age range, parental consent is implied, and he presents with Kawasaki Disease. For exclusion criteria, the patient is not excluded by most criteria, but there is a potential exclusion due to mild anemia, which could indicate abnormal hemoglobin or hematocrit levels. However, without specific values, this is uncertain. Overall, the patient is likely eligible but with a minor concern regarding anemia.",
            "eligibility_score_E": 85.0
        }
    },
    "sigir-20145": {
        "NCT00163709": {
            "relevance_explanation": "The patient is a 56-year-old female presenting to the emergency department with shortness of breath, which aligns with the trial's focus on patients with shortness of breath in the ED. The trial aims to test for heart failure, which is relevant given the patient's symptoms. However, there is no information about the emergency department triage category, which is part of the inclusion criteria.",
            "relevance_score_R": 80.0,
            "eligibility_explanation": "The patient meets the age and symptom requirements for inclusion but lacks information on the emergency department triage category, which is necessary for full inclusion. The patient is not excluded based on the exclusion criteria, as there is no evidence of traumatic dyspnea, severe renal disease, cardiogenic shock, or early transfer. Therefore, the patient is potentially eligible but not fully confirmed due to missing triage information.",
            "eligibility_score_E": 40.0
        }
    },
    "sigir-20146": {
        "NCT00015626": {
            "relevance_explanation": "The clinical trial is focused on preventing complications of insulin resistance and type-2 diabetes, which is relevant to the patient as she is diagnosed with diabetes mellitus and is obese. These conditions are directly related to the trial's target conditions. However, the trial seems to focus on early manifestations and prevention, which may not fully align with the patient's current condition of having persistent diabetes.",
            "relevance_score_R": 70.0,
            "eligibility_explanation": "The patient meets the inclusion criterion of being an obese adult, but there is not enough information to determine eligibility for other inclusion criteria related to complications of insulin resistance or family history. The patient is not excluded based on the ability to give consent, but is excluded due to a history of poor compliance with physician's recommendations. This significantly impacts her eligibility for the trial.",
            "eligibility_score_E": -30.0
        },
        "NCT02512159": {
            "relevance_explanation": "The patient is a 64-year-old female with diabetes mellitus and a painful skin lesion on the left lower leg, which could potentially be a cutaneous leg ulcer. The clinical trial is focused on treating skin ulcers in patients with diabetes mellitus. However, there is no direct mention of venous stasis or arterial insufficiency, which are also target conditions of the trial. The patient meets the age and gender criteria and is willing to provide informed consent.",
            "relevance_score_R": 75.0,
            "eligibility_explanation": "The patient meets several inclusion criteria: she is over 18, female, and has diabetes mellitus. However, there is not enough information to confirm if her skin lesion is a cutaneous leg ulcer due to diabetes mellitus, venous stasis, or arterial insufficiency, and there is no information about basic laboratory tests at admission. The patient is not excluded by any of the exclusion criteria, as there is no evidence of hemodynamic instability, septic shock, deep ulcers, or other specified conditions. Overall, the patient is likely eligible but lacks some specific information required for full inclusion.",
            "eligibility_score_E": 50.0
        }
    },
    "sigir-20147": {
        "NCT01863628": {
            "relevance_explanation": "The clinical trial is focused on recognizing and intervening in the prodromal stage of bipolar disorder, specifically targeting offspring of parents with bipolar disorder. The patient has a history of bipolar disorder and exhibits symptoms relevant to the trial's focus, such as depressive symptoms and signs of hypomania/mania. However, the trial specifically targets offspring of parents with bipolar disorder, and there is no information about the patient's family history of bipolar disorder. This significantly reduces the relevance of the patient to the trial.",
            "relevance_score_R": 30.0,
            "eligibility_explanation": "The patient is excluded due to having a DSM-IV defined Axis I disorder, which is bipolar disorder. Additionally, there is not enough information to confirm the inclusion criteria related to the syndromes required for the prodromal stage. The lack of family history of bipolar disorder also affects eligibility, as the trial specifically targets offspring of parents with bipolar disorder. Therefore, the patient is ineligible for the trial.",
            "eligibility_score_E": -30.0
        },
        "NCT00845988": {
            "relevance_explanation": "The clinical trial is focused on patients with bipolar disorders who have experienced pharmacologically induced weight gain. The patient has a history of bipolar disorder and is experiencing weight issues, making her relevant to the trial. Additionally, she is within the age range specified by the trial.",
            "relevance_score_R": 85.0,
            "eligibility_explanation": "The patient meets the inclusion criteria for having bipolar disorder and being within the age range. She can provide informed consent, but there is no information about her being in syndromal remission for 2 months. There is also no direct evidence of a clinically significant weight gain after starting her current medication. She is not excluded by any of the exclusion criteria. Overall, she is partially eligible but lacks information on some key inclusion criteria.",
            "eligibility_score_E": 40.0
        }
    },
    "sigir-20148": {
        "NCT01519271": {
            "relevance_explanation": "The clinical trial is focused on mild cognitive impairment in Parkinson's Disease, while the patient has severe cognitive deficits and memory dysfunction, which suggests a more advanced condition than mild cognitive impairment. Additionally, there is no mention of Parkinson's Disease in the patient note, which is a key target condition for the trial. Therefore, the relevance between the patient and the trial is low.",
            "relevance_score_R": 20.0,
            "eligibility_explanation": "The patient does not meet the inclusion criteria for mild cognitive impairment, as they have severe cognitive deficits. There is no information about the patient's medication regimen or Parkinson's Disease status, which are important for eligibility. The patient is not excluded based on the available exclusion criteria, but the lack of information on key inclusion criteria and the mismatch in cognitive impairment severity make the patient ineligible for the trial.",
            "eligibility_score_E": -20.0
        },
        "NCT01628315": {
            "relevance_explanation": "The clinical trial is focused on patients with early relapsing-remitting multiple sclerosis (RRMS) and involves specific MRI requirements and prior enrollment in a specific ASA study. The patient has progressive memory loss and jerking movements, with findings suggestive of a neurodegenerative condition, but there is no mention of multiple sclerosis or related MRI studies. Therefore, the patient is not relevant to the trial's target condition or specific study requirements.",
            "relevance_score_R": 10.0,
            "eligibility_explanation": "The patient does not meet the inclusion criteria as there is no evidence of enrollment in the ASA study or MRI performed with a 1.5 T magnet. Additionally, there is no information about MRI image processing or time points, which are relevant to the exclusion criteria. Thus, the patient is not eligible for the trial.",
            "eligibility_score_E": -10.0
        }
    },
    "sigir-20149": {
        "NCT01950026": {
            "relevance_explanation": "The clinical trial is focused on body temperature changes after cryotherapy application, specifically looking at skin reheating in different ethnic groups. The patient has skin lesions and is visiting a dermatologist, which may be relevant to skin-related studies. However, the trial's focus on body temperature changes and specific ethnic groups makes the relevance to this patient limited, as there is no information about the patient's ethnicity or interest in body temperature changes.",
            "relevance_score_R": 30.0,
            "eligibility_explanation": "The patient note does not provide information about the patient's ethnicity, which is required for inclusion. However, the patient is not excluded based on the exclusion criterion, as there is no mention of changes in skin sensitivity, infectious illnesses, or diseases that respond negatively to cold. Therefore, the eligibility is neutral due to lack of information on inclusion but not excluded.",
            "eligibility_score_E": 0.0
        },
        "NCT02615912": {
            "relevance_explanation": "The clinical trial is focused on analyzing skin microflora dynamics in response to surfactants, targeting conditions like dermatitis. The patient has lesions on her neck, which may relate to skin conditions, making her somewhat relevant to the trial. However, the trial specifically targets dermatitis, and the patient's condition is not explicitly identified as such. Therefore, the relevance is moderate.",
            "relevance_score_R": 50.0,
            "eligibility_explanation": "The patient is excluded based on the exclusion criterion, which disallows subjects with visible skin conditions. The patient's lesions are considered a visible skin condition, making her ineligible for the trial. There is also insufficient information to determine if she meets the inclusion criterion regarding skin type.",
            "eligibility_score_E": -50.0
        }
    },
    "sigir-201410": {
        "NCT02264964": {
            "relevance_explanation": "The clinical trial is focused on patients with chronic renal failure requiring hemodialysis and involves the use of non-cuffed catheters. The patient in the note underwent cardiac catheterization via the femoral artery, which is not directly related to the trial's focus on hemodialysis and central venous catheterization. There is no mention of chronic renal failure or hemodialysis in the patient note, which are key aspects of the trial. Therefore, the relevance is low.",
            "relevance_score_R": 20.0,
            "eligibility_explanation": "The patient does not meet the primary inclusion criteria of having chronic renal failure requiring hemodialysis, which is crucial for the trial. The patient is included for providing informed consent and has no history of central venous catheterization, but these are not sufficient to make her eligible given the lack of chronic renal failure. The patient is not excluded by any criteria, but the lack of inclusion in the main criteria results in low eligibility.",
            "eligibility_score_E": -20.0
        },
        "NCT02097186": {
            "relevance_explanation": "The clinical trial is focused on patients undergoing major vascular surgeries such as carotid endarterectomy, abdominal aortic aneurysm repair, or lower limb revascularization. The patient underwent cardiac catheterization, which is not directly related to the surgeries targeted by the trial. However, the patient is of the appropriate age and is willing to provide informed consent, which are relevant factors. Overall, the relevance is limited because the patient's procedure does not align with the specific surgeries of interest in the trial.",
            "relevance_score_R": 30.0,
            "eligibility_explanation": "The patient meets the age and informed consent criteria but does not meet any of the specific surgical inclusion criteria. The patient is not excluded by any of the exclusion criteria, as there is no evidence of conditions or treatments that would disqualify her. However, the lack of inclusion in the specific surgical categories significantly impacts eligibility.",
            "eligibility_score_E": 0.0
        }
    },
    "sigir-201411": {
        "NCT01526382": {
            "relevance_explanation": "The clinical trial is focused on patients with septic shock and acute respiratory distress syndrome (ARDS). The patient presents with symptoms that could suggest shock, such as low blood pressure and tachycardia, but there is no explicit diagnosis of shock or ARDS. The patient meets some criteria related to shock, such as tachycardia and tachypnea, but lacks information on other critical criteria like the use of vasopressors or signs of hypoperfusion. Therefore, the relevance is moderate as the patient shows some symptoms that could be related to the conditions of interest but lacks a definitive diagnosis.",
            "relevance_score_R": 50.0,
            "eligibility_explanation": "The patient meets some inclusion criteria, such as having a heart rate of at least 90/min and a respiratory rate of at least 20/min, which are components of the shock definition. However, there is insufficient information to confirm other necessary criteria for shock, such as the use of vasopressors or signs of hypoperfusion. The patient is not excluded by any exclusion criteria. Overall, the eligibility is low because while the patient shows some relevant symptoms, there is not enough information to confirm full eligibility for the trial.",
            "eligibility_score_E": 10.0
        },
        "NCT01723137": {
            "relevance_explanation": "The clinical trial is focused on measuring changes in acute pain in the emergency department using patient-reported scales. The patient is a 40-year-old woman presenting to the ER with excruciating pain in her right arm, which is highly relevant to the trial's focus on acute pain. She is also able to provide informed consent and comply with the trial protocol, which aligns with the trial's requirements for patient participation.",
            "relevance_score_R": 90.0,
            "eligibility_explanation": "The patient meets the inclusion criterion of reporting pain greater than or equal to 3 out of 10, as she presents with excruciating pain. She is not excluded by any of the exclusion criteria: she is over 18 years old, there is no indication of decreased level of consciousness, she can answer questions, and there is no information suggesting she is a prisoner. Therefore, she is eligible for the trial.",
            "eligibility_score_E": 90.0
        }
    },
    "sigir-201412": {
        "NCT01551498": {
            "relevance_explanation": "The clinical trial is focused on evaluating a dietary supplement for autoimmune thyroiditis. The patient presents with symptoms that could be related to thyroid issues, such as fatigue, hair loss, weight gain, and a cervical mass, which suggests thyroid enlargement. However, there is no direct evidence of autoimmune thyroiditis or positive antibodies against thyroid peroxidase in the patient note. The patient is within the age range for the trial and there are no exclusion criteria that apply based on the available information.",
            "relevance_score_R": 70.0,
            "eligibility_explanation": "The patient meets the age criterion and is not excluded by any of the exclusion criteria. However, there is insufficient information to confirm the presence of positive antibodies against thyroid peroxidase or sonographic evidence of Hashimoto's thyroiditis, which are key inclusion criteria. Therefore, the patient cannot be considered fully eligible for the trial.",
            "eligibility_score_E": 20.0
        },
        "NCT01197183": {
            "relevance_explanation": "The patient exhibits symptoms consistent with hypothyroidism, such as fatigue, hair loss, voice change, weight gain, and cold intolerance, and has a cervical mass that could indicate a thyroid issue. These symptoms are relevant to the clinical trial, which is focused on hypothyroidism. However, there is no direct mention of a formal diagnosis of hypothyroidism within the last 6 months, which is a key inclusion criterion. The patient is willing to provide informed consent and comply with the trial protocol, which is relevant to the trial's requirements.",
            "relevance_score_R": 70.0,
            "eligibility_explanation": "The patient is included based on the criterion of providing informed consent. However, the patient is not included in the key inclusion criterion of having a recent diagnosis of hypothyroidism within the last 6 months, as there is no mention of such a diagnosis. The patient is not excluded by any of the exclusion criteria, as there is no mention of recent participation in another clinical trial, no major risk of not being able to follow-up, and no contraindications to L\u00e9vothyrox. Overall, the lack of a formal diagnosis of hypothyroidism within the specified timeframe significantly impacts eligibility.",
            "eligibility_score_E": 20.0
        },
        "NCT00271427": {
            "relevance_explanation": "The clinical trial is focused on patients with Autoimmune Thyroiditis (AIT), specifically Hashimoto's Thyroiditis, and the effects of Selenium treatment. The patient presents with symptoms that could be indicative of thyroid issues, such as fatigue, hair loss, voice change, weight gain, and cold intolerance, and has a cervical mass, which could suggest a thyroid condition. However, there is no explicit diagnosis of AIT or Hashimoto's Thyroiditis in the patient note. Therefore, while there is some relevance due to the symptoms, the lack of a confirmed diagnosis of AIT reduces the relevance.",
            "relevance_score_R": 50.0,
            "eligibility_explanation": "The inclusion criterion requires a clinically approved diagnosis of AIT and the use of LT4 to maintain TSH levels, which is not confirmed in the patient note. The exclusion criterion is not met as there is no mention of drug use other than LT4 or any pathology affecting GIS absorption. However, without meeting the inclusion criterion, the patient is not eligible for the trial.",
            "eligibility_score_E": -50.0
        }
    },
    "sigir-201413": {
        "NCT02264769": {
            "relevance_explanation": "The clinical trial is focused on postpartum hemorrhage prevention using carbetocin at elective cesarean delivery. The patient recently gave birth, which is relevant to the trial's focus on postpartum conditions. However, there is no indication that the delivery was an elective cesarean under spinal anesthesia, which is a key inclusion criterion. The patient is willing to provide informed consent and had a term pregnancy, which are relevant to the trial. Overall, the relevance is moderate due to the lack of information about the type of delivery.",
            "relevance_score_R": 60.0,
            "eligibility_explanation": "The patient meets the criteria for providing informed consent and having had a term pregnancy. However, she does not meet the crucial inclusion criterion of having undergone an elective cesarean delivery under spinal anesthesia. There is no information suggesting exclusion based on allergies or conditions predisposing to uterine atony. The lack of meeting the primary inclusion criterion significantly impacts eligibility.",
            "eligibility_score_E": -60.0
        },
        "NCT00163709": {
            "relevance_explanation": "The clinical trial is focused on patients presenting to the Emergency Department with shortness of breath, which is relevant to the patient's current condition. However, the trial specifically targets patients over 40 years old, and the patient is only 30 years old. This age mismatch reduces the relevance of the trial to the patient.",
            "relevance_score_R": 50.0,
            "eligibility_explanation": "The patient is not eligible for the trial because she does not meet the inclusion criterion of being over 40 years old. There are no exclusion criteria that apply to her, but failing to meet the inclusion criteria means she cannot participate in the trial.",
            "eligibility_score_E": -50.0
        }
    },
    "sigir-201414": {
        "NCT01869855": {
            "relevance_explanation": "The clinical trial is focused on patients with chronic subdural hematoma, a condition not explicitly mentioned in the patient note. The patient is 85 years old, meeting the age criterion, but there is no evidence of a chronic subdural hematoma diagnosis. The patient's recent car accident and normal head CT do not provide sufficient relevance to the trial's target condition.",
            "relevance_score_R": 30.0,
            "eligibility_explanation": "The patient meets the age requirement but lacks evidence of a chronic subdural hematoma, which is crucial for inclusion. The patient is not excluded based on informed consent, but there is insufficient information to determine eligibility regarding the presence of a chronic subdural hematoma. Therefore, the patient is not eligible for the trial.",
            "eligibility_score_E": -30.0
        },
        "NCT01624545": {
            "relevance_explanation": "The clinical trial is focused on the management of chronic subdural hematoma (CSH) after neurosurgical evacuation. The patient is an 85-year-old man who has experienced a decrease in consciousness and was involved in a car accident 3 weeks ago, but there is no mention of a chronic subdural hematoma diagnosis or recent surgery. The patient meets the age criterion and can provide informed consent, but the lack of information about a CSH diagnosis or surgery significantly reduces the relevance to the trial.",
            "relevance_score_R": 40.0,
            "eligibility_explanation": "The patient meets the age criterion and can provide informed consent, which are positive indicators for eligibility. However, the patient does not meet the critical inclusion criterion of having a newly diagnosed chronic subdural hematoma operated within the last 48 hours. There is no information that excludes the patient based on the exclusion criteria, but the lack of inclusion in the primary criterion makes the patient ineligible for the trial.",
            "eligibility_score_E": -40.0
        }
    },
    "sigir-201415": {
        "NCT00180739": {
            "relevance_explanation": "The clinical trial is focused on women with uterine fibroids who wish to pursue pregnancy in the future. The patient is a 36-year-old woman with an enlarged uterus and multiple cystic areas, which could suggest uterine fibroids. However, there is no confirmed diagnosis of fibroids, nor is there information about her desire for pregnancy. The trial's inclusion criteria are partially relevant to the patient, but there is a lack of specific information confirming her eligibility. The exclusion criteria are mostly not applicable, as the patient does not meet any of the exclusion conditions.",
            "relevance_score_R": 60.0,
            "eligibility_explanation": "The patient fits the age criteria and does not meet any exclusion criteria. However, there is insufficient information to confirm her eligibility for most inclusion criteria, such as the desire for pregnancy, undergoing fertility treatment, or having device-accessible fibroids. The patient is included based on her ability to give consent and comply with the trial protocol, but this alone is not enough to determine full eligibility. Therefore, while the patient is not excluded, she is not fully eligible due to the lack of specific information on key inclusion criteria.",
            "eligibility_score_E": 20.0
        },
        "NCT00277680": {
            "relevance_explanation": "The clinical trial is focused on the treatment of uterine fibroids, specifically comparing two methods: Uterine Fibroid Embolization and laparoscopic occlusion. The patient presents with an enlarged uterus and a differential diagnosis that includes fibroid degeneration, which suggests some relevance to the trial. However, the patient does not have confirmed uterine fibroids or symptoms like menorrhagia or bulk symptoms that are typically associated with fibroids. Therefore, the relevance is moderate.",
            "relevance_score_R": 50.0,
            "eligibility_explanation": "The patient does not meet the inclusion criterion of having menorrhagia or bulk symptoms associated with uterine fibroids, which is crucial for the trial. However, the patient is not excluded by any of the exclusion criteria, as there is no evidence of malignancy, pregnancy, small submucous fibroids, postmenopausal status, adenomyosis, or contraindications to laparoscopic surgery. The uterus size is uncertain in terms of exclusion, but there is not enough information to confirm exclusion. Overall, the patient is not eligible due to not meeting the inclusion criteria.",
            "eligibility_score_E": -50.0
        }
    },
    "sigir-201416": {
        "NCT02374814": {
            "relevance_explanation": "The clinical trial is focused on the immunogenicity of the rabies vaccine for pre-exposure prophylaxis. The patient is a 28-year-old female who recently developed symptoms such as spastic arm movements, sweating, agitation, anxiety, malaise, difficulty swallowing, and hydrophobia after returning from a trip. These symptoms are highly suggestive of rabies, making the trial relevant to her condition. The trial's inclusion criteria include adults aged 18-60 who can provide informed consent and comply with the trial protocol, which the patient meets. However, her current health status is questionable due to her symptoms.",
            "relevance_score_R": 85.0,
            "eligibility_explanation": "While the patient meets the age and gender criteria and can provide informed consent, her current health status with symptoms suggestive of rabies may not classify her as 'in good health,' which is a requirement for inclusion. There is insufficient information regarding her pregnancy status or use of contraception, which affects her eligibility concerning exclusion criteria related to childbearing potential. However, she is not excluded based on other criteria such as participation in other trials, previous rabies vaccination, or rabies immune globulin administration. The presence of anxiety and agitation raises concerns about a potential psychiatric disorder, but there is not enough information to confirm exclusion based on this criterion.",
            "eligibility_score_E": 20.0
        },
        "NCT02238756": {
            "relevance_explanation": "The clinical trial is focused on the safety and tolerability of a rabies vaccine, and the patient presents with symptoms that could be related to rabies exposure, such as hydrophobia and neurological symptoms, after a trip where she might have been exposed to rabies. This makes the patient relevant to the trial as it targets rabies conditions.",
            "relevance_score_R": 85.0,
            "eligibility_explanation": "The patient meets some inclusion criteria, such as compliance with the protocol and having no significant findings on physical examination. However, there is insufficient information about BMI and contraception use, which are important inclusion criteria. The patient is excluded due to acute symptoms that may interfere with safety assessment and potential neurological disorders. These exclusions significantly impact eligibility.",
            "eligibility_score_E": -50.0
        }
    },
    "sigir-201417": {
        "NCT02556359": {
            "relevance_explanation": "The clinical trial is focused on understanding DNA repair mechanisms in immune deficiencies, specifically targeting conditions like CVID. The patient has a history of CVID, which is directly relevant to the trial's objectives. However, the trial also targets early bone marrow failure in childhood, which does not apply to this 48-year-old patient. Additionally, there is no information about the patient being a genetic patient, which is another focus of the trial.",
            "relevance_score_R": 70.0,
            "eligibility_explanation": "The patient meets the inclusion criterion for having CVID, which is a key focus of the trial. The patient does not meet the inclusion criterion related to childhood conditions, as he is 48 years old. There is insufficient information to determine if the patient meets the criterion for being a genetic patient. The patient is not excluded based on the criterion of refusal to consent, as he is willing to provide informed consent. Overall, the patient is eligible based on the CVID criterion and not excluded by any criteria.",
            "eligibility_score_E": 40.0
        },
        "NCT01745731": {
            "relevance_explanation": "The patient is a 48-year-old male with a ruptured liver abscess, which is a liver space-occupying lesion. This is relevant to the trial as it involves liver conditions and potential liver surgery. The patient is also willing to provide informed consent and comply with the trial protocol, which is relevant for participation in any clinical trial.",
            "relevance_score_R": 70.0,
            "eligibility_explanation": "The patient meets the age and gender requirement and has a liver space-occupying lesion, which are relevant inclusion criteria. The patient is also willing to provide informed consent. However, there is insufficient information on several other inclusion criteria such as standard analytical parameters, leukocyte count, and liver function tests. The patient does not meet some specific inclusion criteria related to metastatic disease and specific types of liver damage. The patient is not excluded by any exclusion criteria. Overall, the patient is partially eligible but lacks information for full eligibility.",
            "eligibility_score_E": 30.0
        }
    },
    "sigir-201418": {
        "NCT00557219": {
            "relevance_explanation": "The clinical trial is focused on preventing acute kidney failure in patients who have undergone cardiac surgery. The patient is a 6-month-old infant who has undergone major surgery and is experiencing symptoms indicative of acute kidney issues, such as oliguria and generalized edema. However, it is not specified that the surgery was cardiac, which is a key requirement for the trial. Despite this, the patient's condition is relevant to the trial's focus on acute renal failure post-surgery.",
            "relevance_score_R": 60.0,
            "eligibility_explanation": "The patient meets some of the inclusion criteria, such as having risk factors for acute renal failure and experiencing oliguria. However, the lack of information about the type of surgery (cardiac or not) and the administration of furosemide affects eligibility. The patient is not excluded by any of the exclusion criteria. Overall, the patient is partially eligible due to meeting some inclusion criteria but not all, particularly the critical one regarding the type of surgery.",
            "eligibility_score_E": 30.0
        },
        "NCT01260883": {
            "relevance_explanation": "The patient is a 6-month-old male infant who has undergone major surgery, which fits the trial's target population of infants aged 2-18 months who have undergone surgery. The trial is focused on postoperative pain management in infants, which is relevant to the patient's current postoperative status.",
            "relevance_score_R": 90.0,
            "eligibility_explanation": "The patient meets the inclusion criteria as a 6-month-old infant who has undergone surgery. However, the patient is excluded due to potential renal impairment, as indicated by elevated blood urea nitrogen and serum creatinine levels. This suggests the presence of renal disease, which is an exclusion criterion for the trial.",
            "eligibility_score_E": -90.0
        }
    },
    "sigir-201419": {
        "NCT02509286": {
            "relevance_explanation": "The patient is a 52-year-old man with symptoms suggestive of esophageal issues, such as progressive dysphagia and significant weight loss. The clinical trial is focused on patients with esophageal adenocarcinoma, which could be relevant given the patient's symptoms. However, there is no direct evidence in the patient note confirming a diagnosis of esophageal adenocarcinoma or any specific cancer staging information. The patient is willing to provide informed consent, which is relevant to the trial's requirements.",
            "relevance_score_R": 60.0,
            "eligibility_explanation": "The patient meets the age criterion and is willing to provide informed consent, which are two inclusion criteria. However, there is insufficient information regarding the diagnosis of esophageal adenocarcinoma, cancer staging, and other health parameters such as cardiac, bone marrow, respiratory, renal, and liver function. Additionally, there is no information on prior treatments or other exclusion criteria. Therefore, the eligibility is limited by the lack of specific medical details required for the trial.",
            "eligibility_score_E": 10.0
        },
        "NCT00256529": {
            "relevance_explanation": "The patient is a 52-year-old man presenting with progressive dysphagia, which is directly relevant to the clinical trial focused on patients with dysphagia to study eosinophilic esophagitis. The trial is looking for patients within the age range of 18-90 with dysphagia, which the patient fits. Therefore, the patient is highly relevant to the trial.",
            "relevance_score_R": 90.0,
            "eligibility_explanation": "The patient meets the inclusion criteria of being aged 18-90 and presenting with dysphagia. There is no information suggesting the patient cannot undergo esophagogastroduodenoscopy and biopsies, nor is there any indication of significant cardiopulmonary disease or other contraindications to EGD. The patient is not excluded by any of the exclusion criteria, as there are no contraindications to EGD, the patient can provide informed consent, and there is no mention of esophageal varices. However, there is not enough information to confirm the ability to undergo EGD and biopsies, which slightly reduces the eligibility score.",
            "eligibility_score_E": 80.0
        }
    },
    "sigir-201420": {
        "NCT02418169": {
            "relevance_explanation": "The clinical trial is focused on patients with craniofacial fractures or severe traumatic brain injuries, which are not mentioned in the patient's note. The patient has multiple fractures but none are specified as craniofacial, and there is no indication of a brain injury or a low GCS score. Therefore, the relevance of this patient to the trial is low.",
            "relevance_score_R": 20.0,
            "eligibility_explanation": "The patient does not meet the inclusion criteria as there is no evidence of craniofacial fractures or severe traumatic brain injury. The exclusion criterion is not applicable as the patient is alive. Thus, the patient is not eligible for the trial.",
            "eligibility_score_E": -20.0
        },
        "NCT01594385": {
            "relevance_explanation": "The patient is a 32-year-old woman who has sustained multiple injuries from a car accident, making her a trauma patient. The clinical trial is focused on trauma patients undergoing open abdomen damage control management. However, there is no direct evidence that the patient is undergoing such management, which is a key aspect of the trial. The patient meets the age criterion and is likely to have a life expectancy longer than 48 hours. There are no indications that she is a prisoner or pregnant, which are exclusion criteria. Overall, the patient is relevant to the trial due to her trauma status, but the lack of information on open abdomen management reduces the relevance.",
            "relevance_score_R": 70.0,
            "eligibility_explanation": "The patient meets the age criterion and is likely to have a life expectancy longer than 48 hours, which are inclusion criteria. There is no information indicating she is a prisoner or pregnant, which are exclusion criteria. However, the key inclusion criterion of undergoing damage control/open abdomen management is not confirmed, which is crucial for eligibility. Therefore, while the patient is not excluded by any criteria, the lack of confirmation on the main inclusion criterion limits her eligibility.",
            "eligibility_score_E": 30.0
        },
        "NCT02255487": {
            "relevance_explanation": "The patient is a 32-year-old woman who has sustained abdominal trauma, which is relevant to the clinical trial focused on preventing surgical site infections in patients undergoing open abdominal laparotomy for abdominal trauma or acute surgical abdomen. The patient meets the age and gender criteria, and she is willing to provide informed consent, which aligns with the trial's inclusion criteria.",
            "relevance_score_R": 90.0,
            "eligibility_explanation": "The patient meets all the inclusion criteria: she is over 18, willing to provide informed consent, and has experienced abdominal trauma requiring surgical intervention. There is no information in the patient note that excludes her based on the exclusion criteria, such as allergies, high AIS or ASA scores, pregnancy, or prior abdominal incisions. Therefore, she is likely eligible for the trial.",
            "eligibility_score_E": 90.0
        }
    },
    "sigir-201421": {
        "NCT00997100": {
            "relevance_explanation": "The patient is a 21-year-old female with symptoms and laboratory findings consistent with systemic lupus erythematosus (SLE), including arthritis, rash, alopecia, and positive ANA and anti-dsDNA. The clinical trial is focused on patients with mild active SLE, which matches the patient's condition. The trial aims to study changes in disease activity and biomarkers in SLE patients, and the patient presents with relevant symptoms such as joint involvement and skin rash. Therefore, the patient is highly relevant to the trial.",
            "relevance_score_R": 95.0,
            "eligibility_explanation": "The patient meets several inclusion criteria, such as being over 18 years old, fulfilling at least 4 criteria for SLE, presenting with active SLE symptoms, and having the ability to provide informed consent and comply with the trial protocol. However, there is insufficient information regarding some laboratory values required by the inclusion criteria, such as hemoglobin, neutrophil count, bilirubin, and liver enzymes. The patient is not excluded by any exclusion criteria based on the available information. Therefore, the patient is likely eligible but requires additional laboratory data to confirm full eligibility.",
            "eligibility_score_E": 75.0
        },
        "NCT01520155": {
            "relevance_explanation": "The patient is highly relevant to the clinical trial as she has systemic Lupus erythematosus (SLE), which is the target condition of the study. The patient's symptoms, lab findings, and renal involvement align with the trial's focus on SLE and its potential cardiovascular risks.",
            "relevance_score_R": 100.0,
            "eligibility_explanation": "The patient meets the inclusion criterion of having systemic Lupus erythematosus, as evidenced by her symptoms and lab results. There are no applicable exclusion criteria that would disqualify her from the trial. Therefore, she is fully eligible for participation.",
            "eligibility_score_E": 100.0
        }
    },
    "sigir-201422": {
        "NCT00723788": {
            "relevance_explanation": "The patient is a 15-year-old girl presenting with symptoms consistent with appendicitis, including right lower quadrant pain and an edematous appendix on ultrasound. The clinical trial is focused on diagnosing appendicitis in children using MRI, and the patient fits the age range and condition targeted by the trial. She has already undergone an ultrasound, which aligns with the trial's criteria for participants who have received either a CT scan or ultrasound.",
            "relevance_score_R": 95.0,
            "eligibility_explanation": "The patient meets the inclusion criteria as she is within the age range of 8-18 years, was referred from the emergency department with suspected appendicitis, and has received an ultrasound for diagnosis. There are no exclusion criteria applicable to her, as there is no mention of issues with MRI metal screening, claustrophobia, or the need for sedation. Therefore, she is eligible for the trial.",
            "eligibility_score_E": 95.0
        },
        "NCT00236912": {
            "relevance_explanation": "The patient is a 15-year-old girl presenting with symptoms of acute appendicitis, including abdominal pain and rebound tenderness, and has radiologic evidence of an edematous appendix. The clinical trial is focused on treating complicated appendicitis, which typically involves a ruptured appendix. The patient note does not indicate that the appendicitis is complicated, which is a key aspect of the trial. Therefore, while the patient is relevant to the general condition of appendicitis, she may not be relevant to the specific focus on complicated appendicitis.",
            "relevance_score_R": 60.0,
            "eligibility_explanation": "The patient does not meet the inclusion criteria for the trial. She has symptoms of acute appendicitis but lacks evidence of complicated appendicitis, which is required. Additionally, there is no information about her ability to take medicine orally after surgery, and she is not using birth control, which is another inclusion criterion. However, she does not meet any of the exclusion criteria, as there is no evidence of allergies to study medications, short life expectancy, high APACHE II score, neutropenia, HIV, low platelet count, malnutrition, or conditions requiring major tranquilizers. Overall, the patient is not eligible for the trial due to not meeting the inclusion criteria.",
            "eligibility_score_E": -60.0
        }
    },
    "sigir-201423": {
        "NCT00170222": {
            "relevance_explanation": "The patient is a 63-year-old man presenting with symptoms consistent with an acute exacerbation of COPD, such as cough, shortness of breath, and use of home oxygen. The clinical trial is focused on evaluating the efficacy of antibiotics in acute exacerbations of COPD. The patient's symptoms and medical history make him highly relevant to the trial's target condition.",
            "relevance_score_R": 95.0,
            "eligibility_explanation": "The patient meets all inclusion criteria: he has an acute exacerbation of COPD, can perform lung function tests, and can take oral medication. He is not excluded by any of the exclusion criteria, as there is no evidence of pretreatment with antibiotics or corticosteroids, no progression on chest X-ray, no severe exacerbation requiring mechanical ventilation, and no history of conditions that would exclude him. Therefore, the patient is fully eligible for the trial.",
            "eligibility_score_E": 95.0
        },
        "NCT02219360": {
            "relevance_explanation": "The patient is a 63-year-old man presenting with symptoms consistent with an acute exacerbation of COPD, such as cough, shortness of breath, and difficulty breathing. These symptoms align with the target condition of the clinical trial, which is focused on acute exacerbation of chronic obstructive pulmonary disease. However, the patient note does not explicitly mention hospitalization, which is a key inclusion criterion for the trial. Despite this, the patient's age and symptomatology are highly relevant to the trial's focus.",
            "relevance_score_R": 85.0,
            "eligibility_explanation": "The patient meets the age criterion (being 63 years old) and does not have any exclusionary conditions such as congestive heart failure, lung cancer, or serious organ dysfunctions. However, there is insufficient information to confirm hospitalization due to acute exacerbation of COPD, which is a critical inclusion criterion. Therefore, while the patient is not excluded by any criteria, the lack of confirmation regarding hospitalization limits the eligibility.",
            "eligibility_score_E": 60.0
        }
    },
    "sigir-201424": {
        "NCT01594385": {
            "relevance_explanation": "The patient is a 33-year-old male who has suffered a traumatic injury resulting in a spleen rupture, which aligns with the trial's focus on trauma patients undergoing damage control management. The trial is relevant to patients with open abdomen and traumatic injuries, which matches the patient's condition.",
            "relevance_score_R": 90.0,
            "eligibility_explanation": "The patient meets all the inclusion criteria: he is a trauma patient likely undergoing damage control management, is over 18 years old, and there is no indication that his life expectancy is less than 48 hours. He is not excluded by any exclusion criteria, as he is not a prisoner, not pregnant, and is older than 18 years. Therefore, the patient is eligible for the trial.",
            "eligibility_score_E": 90.0
        },
        "NCT02378311": {
            "relevance_explanation": "The clinical trial is focused on injuries related to handlebar grips in children aged 0-15 years. The patient is a 33-year-old male who sustained an abdominal injury from a bicycle accident. While the mechanism of injury (bicycle accident) is relevant, the age criterion is not met, making the patient largely irrelevant to the trial's target population.",
            "relevance_score_R": 20.0,
            "eligibility_explanation": "The patient does not meet the primary inclusion criterion of being a child aged 0-15 years, which is critical for this trial. Although the patient sustained a relevant type of injury (bicycle-related), the age mismatch makes him ineligible for the trial. Therefore, the eligibility score is negative, reflecting the patient's ineligibility due to not meeting the age requirement.",
            "eligibility_score_E": -20.0
        },
        "NCT01771861": {
            "relevance_explanation": "The clinical trial is focused on evaluating trauma team activation criteria and involves patients with trauma or injuries. The patient in question has suffered a spleen rupture and extended intraperitoneal hemorrhage due to blunt trauma, which aligns with the target conditions of the trial. However, there is no explicit mention of the patient being admitted with the trauma team, which is a key aspect of the trial's inclusion criteria. The patient's condition is relevant to the trial's focus on trauma and emergency procedures.",
            "relevance_score_R": 70.0,
            "eligibility_explanation": "The patient has severe injuries that could potentially meet the Injury Severity Score >15 criterion, but this is not explicitly stated. The patient is not excluded based on the secondary admittance criterion, as there is no mention of a transfer more than 24 hours post-injury. However, the lack of information about trauma team admission and the Injury Severity Score makes it difficult to confirm eligibility. Therefore, the patient is not clearly eligible or ineligible based on the available information.",
            "eligibility_score_E": 20.0
        },
        "NCT02229695": {
            "relevance_explanation": "The patient is a 33-year-old male who has suffered blunt abdominal trauma leading to a spleen rupture and extended intraperitoneal hemorrhage. This condition likely necessitates an emergency laparotomy, which aligns with the trial's focus on patients undergoing operations with temporary abdominal closure due to trauma. The trial is investigating methods of temporary abdominal closure, which is relevant to the patient's situation.",
            "relevance_score_R": 85.0,
            "eligibility_explanation": "The patient meets the inclusion criteria as an adult male likely undergoing emergency laparotomy due to trauma. However, there is uncertainty regarding the exclusion criterion related to the surgeon's estimate of survival for 24 hours. The patient's critical condition suggests a risk, but without explicit documentation of the surgeon's estimate, eligibility cannot be fully determined. Thus, the patient is included in the inclusion criteria but has uncertain status regarding the exclusion criterion.",
            "eligibility_score_E": 40.0
        }
    },
    "sigir-201425": {
        "NCT01869855": {
            "relevance_explanation": "The clinical trial is focused on evaluating treatments for chronic subdural hematoma in adults, specifically comparing subperiosteal and subdural drainage methods. The patient is an 8-year-old boy who suffered an acute head injury, which is not related to chronic subdural hematoma. Therefore, the patient is not relevant to the trial's target condition or age group.",
            "relevance_score_R": 10.0,
            "eligibility_explanation": "The patient does not meet the inclusion criteria as he is under 18 years old and does not have a chronic subdural hematoma. The exclusion criteria are not applicable or not met, but since the patient does not meet any inclusion criteria, he is ineligible for the trial.",
            "eligibility_score_E": -10.0
        },
        "NCT00282269": {
            "relevance_explanation": "The clinical trial is focused on children with severe traumatic brain injury, which is relevant to the patient who is an 8-year-old boy with a severe traumatic brain injury as indicated by a GCS of 6/15. The trial's age range of 1 to 16 years also matches the patient's age. However, there is a lack of information regarding the CT scan results and mechanical ventilation status, which are important for full relevance.",
            "relevance_score_R": 80.0,
            "eligibility_explanation": "The patient meets the age criterion and is not excluded by any of the exclusion criteria. However, there is insufficient information to confirm eligibility for the inclusion criteria related to the CT scan and mechanical ventilation. The lack of CT scan results and mechanical ventilation status prevents full eligibility confirmation.",
            "eligibility_score_E": 40.0
        },
        "NCT02378311": {
            "relevance_explanation": "The patient is an 8-year-old boy who sustained an injury from a fall off a bicycle, which aligns with the target conditions of the trial focusing on injuries in children related to cycling. The trial is investigating injuries associated with bicycles, and the patient was transferred to a hospital for treatment, making him relevant to the study.",
            "relevance_score_R": 95.0,
            "eligibility_explanation": "The patient meets all the inclusion criteria: he is within the age range, presented to a hospital for treatment, sustained an injury, and the injury was due to a non-motorized bicycle. He is not excluded by any of the exclusion criteria, as there is no indication of a motor vehicle collision, injury by another rider, presence of 'bull bars', language barriers, or death. Therefore, the patient is fully eligible for the trial.",
            "eligibility_score_E": 95.0
        }
    },
    "sigir-201427": {
        "NCT01187901": {
            "relevance_explanation": "The patient is a 21-year-old with a family history of multiple polyps and has been found to have dozens of small colonic polyps, which suggests a clinical diagnosis of FAP or attenuated FAP. This is directly relevant to the trial, which targets patients with familial adenomatous polyposis (FAP) or attenuated FAP (AFAP).",
            "relevance_score_R": 85.0,
            "eligibility_explanation": "The patient meets the key inclusion criteria of being 18 years or older with a clinical diagnosis of FAP or attenuated FAP and is willing to provide informed consent. However, there is no information on the presence of duodenal polyps, recent surgeries, performance status, bone marrow function, liver function, or NSAID use, which are required for full eligibility. The patient is not excluded by any of the exclusion criteria. Therefore, the patient is partially eligible but lacks information for full eligibility.",
            "eligibility_score_E": 40.0
        },
        "NCT01713881": {
            "relevance_explanation": "The clinical trial is focused on patients who have undergone colonoscopy and were found to have tubular adenomas, specifically between the years 2004-2008. The patient in the note has undergone a sigmoidoscopy and was found to have benign adenomas, which aligns with the trial's focus on adenomas. However, the trial is retrospective and involves reviewing past records from 2004-2008, which does not directly apply to the current patient. Despite this, the patient's condition is relevant to the general topic of colon adenoma surveillance.",
            "relevance_score_R": 50.0,
            "eligibility_explanation": "The patient meets both inclusion criteria: they have adenomas found on a screening procedure and are over 18 years old. The patient is not excluded by the exclusion criteria, as they are not under 18 and there is no diagnosis of IBD. However, the trial's retrospective nature and specific time frame (2004-2008) mean the patient cannot be included in this specific study, as it is not recruiting new patients but reviewing past records.",
            "eligibility_score_E": 0.0
        }
    },
    "sigir-201429": {
        "NCT01978834": {
            "relevance_explanation": "The patient is a 51-year-old woman concerned about osteoporosis, which aligns with the clinical trial's focus on osteoporosis in women aged 50 to 89. The trial aims to validate a diagnostic tool for osteoporosis, which is relevant to the patient's interest in osteoporosis prevention.",
            "relevance_score_R": 90.0,
            "eligibility_explanation": "The patient meets all inclusion criteria: she is female and within the age range of 50 to 89 years. None of the exclusion criteria apply to her, as she can provide informed consent, has no cognitive impairments, and there are no indications of conditions that would preclude participation (e.g., hip replacements, open wounds).",
            "eligibility_score_E": 90.0
        },
        "NCT00703417": {
            "relevance_explanation": "The clinical trial is focused on understanding bone structure differences in postmenopausal women with Type II diabetes, particularly in relation to fracture risk. The patient is a 51-year-old postmenopausal woman concerned about osteoporosis, which aligns with the trial's focus on bone health. However, she is below the age range of 55-75 years and has diet-controlled diabetes without confirmation of Type II diabetes or treatment with insulin or oral therapies. These factors reduce her relevance to the trial.",
            "relevance_score_R": 40.0,
            "eligibility_explanation": "The patient does not meet the inclusion criteria due to her age being below the required range and lack of confirmation of Type II diabetes with specific treatment. She is not excluded by any of the exclusion criteria, but the lack of inclusion makes her ineligible for the trial.",
            "eligibility_score_E": -40.0
        }
    },
    "sigir-201430": {
        "NCT02097186": {
            "relevance_explanation": "The patient is a 72-year-old man with a history of cardiovascular issues, including a myocardial infarction and transient ischemic attack, and presents with symptoms suggestive of peripheral vascular disease, such as calf pain when walking uphill and diminished pulses in the lower extremities. The clinical trial is focused on patients undergoing major vascular surgery, particularly those with conditions like carotid atherosclerosis and critical lower limb ischemia. While the patient has some relevant symptoms and conditions, there is no direct evidence that he is scheduled for any of the specific surgeries mentioned in the inclusion criteria. However, his condition and symptoms suggest he could be a candidate for such surgeries, making him somewhat relevant to the trial.",
            "relevance_score_R": 60.0,
            "eligibility_explanation": "The patient meets the basic inclusion criteria of age and willingness to provide informed consent. However, there is no information confirming that he is undergoing any of the specific surgeries required for inclusion in the trial. On the exclusion side, the patient does not meet any of the exclusion criteria, which is favorable for eligibility. Overall, while the patient is not excluded, the lack of information about undergoing the required surgeries limits his eligibility.",
            "eligibility_score_E": 20.0
        },
        "NCT02273232": {
            "relevance_explanation": "The patient exhibits symptoms consistent with peripheral vascular disease (PVD), such as calf pain when walking and diminished pulses in the lower extremities, which aligns with the target condition of the trial. However, there is no explicit diagnosis of moderate PVD or specific staging information (Rutherford stage 2 or Fontaine stage 2a) provided in the patient note. The trial focuses on the effects of remote ischemic preconditioning on PVD, which is relevant to the patient's symptoms.",
            "relevance_score_R": 70.0,
            "eligibility_explanation": "The patient shows potential relevance to the trial due to symptoms indicative of PVD, but lacks a confirmed diagnosis of moderate PVD or specific staging information required by the inclusion criteria. The patient is not excluded by any of the exclusion criteria, as there is no evidence of severe cardiac or respiratory conditions, contraindications for MRA, or medications that affect RIPC. However, the lack of specific inclusion criteria fulfillment (diagnosis and staging) limits the eligibility.",
            "eligibility_score_E": 20.0
        },
        "NCT00721006": {
            "relevance_explanation": "The clinical trial is focused on patients with severe leg ischemia, particularly those with claudication and poor circulation who are not candidates for surgical procedures. The patient is a 72-year-old male with claudication, as evidenced by calf pain when walking uphill, and has a history of cardiovascular issues, which makes him relevant to the trial. However, there is no direct mention of an ABI measurement or whether the patient is not a candidate for surgical procedures, which are important criteria for the trial.",
            "relevance_score_R": 70.0,
            "eligibility_explanation": "The patient meets the age criterion and has claudication, which are positive indicators for inclusion. However, there is no information on ABI measurements or whether the patient is not a candidate for surgical procedures, which are critical for full eligibility. The patient is not excluded by any of the exclusion criteria, as he can provide informed consent and has no history of angiogenic therapy or other exclusionary conditions. Overall, the lack of information on key inclusion criteria limits the eligibility score.",
            "eligibility_score_E": 30.0
        }
    },
    "sigir-20151": {
        "NCT01142245": {
            "relevance_explanation": "The clinical trial is focused on patients with peptic ulcer hemorrhage who are at risk for recurrent bleeding. The patient presented with symptoms suggestive of upper gastrointestinal bleeding, such as 'coffee ground' vomiting, and is in a critical condition requiring ICU care. However, there is no specific confirmation of peptic ulcer bleeding or endoscopic findings, which are central to the trial's focus. The patient is of appropriate age and can provide informed consent, which aligns with some of the trial's inclusion criteria.",
            "relevance_score_R": 70.0,
            "eligibility_explanation": "The patient meets the age criterion and can provide informed consent, which are positive indicators for eligibility. However, there is insufficient information to confirm the presence of peptic ulcer bleeding with specific Forrest classification or that endoscopic hemostasis was achieved, which are crucial inclusion criteria. The patient is not excluded by any of the exclusion criteria, as there is no evidence of conditions like upper GI malignancy, esophageal varices, or recent PPI use. Overall, the lack of specific endoscopic findings limits the eligibility.",
            "eligibility_score_E": 30.0
        },
        "NCT00843063": {
            "relevance_explanation": "The clinical trial is focused on preventing recurrent peptic ulcers or erosions in patients taking low-dose aspirin. The patient presented with gastrointestinal bleeding, which could be related to peptic ulcers or erosions, but there is no mention of low-dose aspirin use, which is a key aspect of the trial. The patient meets the age criterion but lacks other relevant details such as aspirin use or endoscopic findings.",
            "relevance_score_R": 30.0,
            "eligibility_explanation": "The patient meets the age criterion but does not meet any other inclusion criteria, as there is no evidence of low-dose aspirin use or endoscopic findings of ulcers or erosions. The patient is not excluded by any exclusion criteria. Therefore, the patient is mostly ineligible due to the lack of inclusion criteria fulfillment.",
            "eligibility_score_E": -30.0
        }
    },
    "sigir-20152": {
        "NCT02532452": {
            "relevance_explanation": "The patient is highly relevant to the clinical trial as he is immunocompromised and has evidence of a viral infection, which aligns with the trial's target conditions. The trial is focused on treating viral infections in immunocompromised hosts, and the patient fits this profile. Additionally, the patient is willing to provide informed consent and comply with the trial protocol.",
            "relevance_score_R": 90.0,
            "eligibility_explanation": "The patient meets several inclusion criteria: he is immunocompromised with evidence of viral infection, is over 1 day old, and is willing to provide informed consent. There is no information to suggest he is excluded based on the exclusion criteria provided. However, there is insufficient information regarding the ability to taper steroids, receive CTL infusion in Cincinnati, and whether he has had a stem cell transplant. These unknowns prevent a full eligibility determination, but the patient is likely eligible based on the available information.",
            "eligibility_score_E": 60.0
        },
        "NCT00034437": {
            "relevance_explanation": "The patient is relevant to the clinical trial as he is within the age range of 18-65, has evidence of CMV infection (owl's eye inclusion bodies), and is willing to provide informed consent. These factors align with the trial's focus on immune responses to CMV in individuals who have been exposed to the virus.",
            "relevance_score_R": 90.0,
            "eligibility_explanation": "The patient meets all the inclusion criteria: he is within the age range, likely CMV seropositive, and willing to provide informed consent. However, he is excluded due to being on immunosuppressive medications, which suggests an immunodeficiency state. This exclusion criterion significantly impacts his eligibility.",
            "eligibility_score_E": -90.0
        }
    },
    "sigir-20153": {
        "NCT01326507": {
            "relevance_explanation": "The clinical trial is focused on patients with acute pulmonary embolism, and the patient presents with symptoms consistent with this condition, such as shortness of breath, tachypnea, and chest pain. However, there is no confirmed diagnosis of acute pulmonary embolism in the patient note, which is crucial for relevance. The patient is not under guardianship, has no mention of social insurance issues, is male (thus not pregnant), is willing to provide informed consent, and has no recent myocardial infarction, which aligns with the exclusion criteria.",
            "relevance_score_R": 70.0,
            "eligibility_explanation": "The patient is not included in the trial because there is no confirmed diagnosis of acute pulmonary embolism, which is a key inclusion criterion. However, the patient is not excluded by any of the exclusion criteria, as he is not under guardianship, has no social insurance issues mentioned, is male, is willing to provide informed consent, and has no recent myocardial infarction. Therefore, the eligibility score is negative but not at the extreme, reflecting the lack of inclusion but no exclusion.",
            "eligibility_score_E": -35.0
        },
        "NCT01935141": {
            "relevance_explanation": "The patient presents with symptoms such as shortness of breath and chest pain, which could indicate a pulmonary embolism, a target condition of the trial. However, there is no direct mention of the patient being referred for a CT pulmonary angiogram to exclude pulmonary embolus, which is the specific inclusion criterion. The patient's recent surgery and symptoms make it plausible that a pulmonary embolism is suspected, but this is not explicitly stated.",
            "relevance_score_R": 70.0,
            "eligibility_explanation": "The patient is not explicitly referred for a CT pulmonary angiogram, which is required for inclusion, leading to uncertainty about meeting the inclusion criterion. However, the patient does not have any of the exclusion criteria such as congestive heart failure, supraventricular tachycardia, contrast allergy, inability to give informed consent, or known elevated serum creatinine levels. Therefore, the patient is not excluded but also not clearly included.",
            "eligibility_score_E": 20.0
        }
    },
    "sigir-20154": {
        "NCT01243255": {
            "relevance_explanation": "The clinical trial is focused on evaluating the efficacy of hypercholesterolemia treatment in Polish patients. The patient has hypercholesterolemia, which is relevant to the trial's target condition. However, there is no direct evidence in the patient note that she is currently on lipid-lowering therapy, which is a key aspect of the trial. Additionally, the trial is specific to Polish patients, and there is no information about the patient's nationality. Therefore, the relevance is moderate.",
            "relevance_score_R": 50.0,
            "eligibility_explanation": "The patient has hypercholesterolemia, which is relevant to the trial. However, there is no information about whether she is on lipid-lowering therapy, the duration of such therapy, or any changes in medication, which are crucial inclusion criteria. The patient is willing to provide informed consent, which is positive. However, there is no information about a blood sample for lipid profile and glucose, which is an exclusion criterion. Given these uncertainties, the patient is likely ineligible for the trial.",
            "eligibility_score_E": -50.0
        },
        "NCT00844987": {
            "relevance_explanation": "The patient is highly relevant to the clinical trial as she presents with acute coronary syndrome (ACS) symptoms, including typical chest pain and ST-segment elevation, which are key conditions targeted by the trial. Additionally, she underwent coronary angiography, aligning with the trial's focus on myocardial injury markers and growth factors in ACS patients.",
            "relevance_score_R": 95.0,
            "eligibility_explanation": "The patient meets all inclusion criteria: she has typical chest pain, ST-segment elevation, and underwent coronary angiography. She also does not meet any exclusion criteria, as there is no known past history of myocardial infarction and she will provide informed consent. Therefore, she is fully eligible for the trial.",
            "eligibility_score_E": 95.0
        }
    },
    "sigir-20155": {
        "NCT02118818": {
            "relevance_explanation": "The clinical trial is focused on studying the genetics of Rheumatic Heart Disease (RHD), which is a complication of rheumatic fever. The patient is a 31-year-old woman presenting with joint pain, fatigue, intermittent fevers, and chest pain, which could be suggestive of rheumatic fever. However, there is no mention of a diagnosis of RHD or any echocardiographic findings in the patient note. Therefore, while the symptoms might be relevant to rheumatic fever, the lack of specific mention of RHD reduces the relevance to the trial.",
            "relevance_score_R": 40.0,
            "eligibility_explanation": "The inclusion criterion requires clinical and echocardiographic signs of RHD, which the patient does not have according to the note. The exclusion criterion is congenital heart disease, which the patient does not have. Since the patient does not meet the inclusion criterion and is not excluded by the exclusion criterion, the eligibility score is negative, reflecting ineligibility.",
            "eligibility_score_E": -40.0
        },
        "NCT02407106": {
            "relevance_explanation": "The clinical trial is focused on children with a history of rheumatic fever, specifically targeting the prevention of streptococcal throat infections in this population. The patient is a 31-year-old woman with joint pain, fatigue, and intermittent fevers, but there is no mention of a history of rheumatic fever or rheumatic heart disease. Therefore, the patient is not directly relevant to the trial's target population, which is children with a history of rheumatic fever.",
            "relevance_score_R": 10.0,
            "eligibility_explanation": "The patient does not meet the inclusion criterion of having rheumatic heart disease with recommended strep prophylaxis, as there is no indication of rheumatic fever or heart disease in the patient note. The exclusion criteria are not applicable to the patient, as she is not a child and there is no refusal to take tablets. However, since the patient does not meet the key inclusion criterion, she is ineligible for the trial.",
            "eligibility_score_E": -10.0
        }
    },
    "sigir-20156": {
        "NCT01717352": {
            "relevance_explanation": "The clinical trial is focused on weight loss strategies for individuals who are overweight or obese. The patient has experienced significant weight loss and symptoms suggestive of a metabolic condition, but there is no direct evidence of overweight or obesity. The patient's age is within the eligible range, but the lack of information on BMI and the focus on weight loss for overweight individuals makes the relevance moderate.",
            "relevance_score_R": 50.0,
            "eligibility_explanation": "The patient meets the age criterion but does not have enough information to confirm eligibility for the BMI criterion, which is crucial for this trial. There is also insufficient information regarding sleep duration and medication use affecting sleep. The patient is not excluded based on the available exclusion criteria. Overall, the lack of key information about BMI and sleep patterns results in a neutral eligibility score.",
            "eligibility_score_E": 0.0
        },
        "NCT02375451": {
            "relevance_explanation": "The clinical trial is focused on the effects of radioiodine therapy on salivary function, specifically in pediatric patients. The patient is a 46-year-old woman with symptoms suggestive of hyperthyroidism, which is one of the target conditions of the trial. However, the trial is specifically interested in pediatric patients, and there is no indication that the patient has received radioiodine therapy, which is a key aspect of the trial. Therefore, the relevance is limited.",
            "relevance_score_R": 30.0,
            "eligibility_explanation": "The patient is potentially eligible for the negative control group, as there is no indication she has received radioiodine therapy. However, the trial is focused on pediatric patients, and the patient is an adult. This significantly limits her eligibility. Additionally, the exclusion criterion regarding language is not applicable, but the focus on pediatric patients excludes her from the trial.",
            "eligibility_score_E": -30.0
        }
    },
    "sigir-20157": {
        "NCT01632319": {
            "relevance_explanation": "The patient is a 20-year-old female college student experiencing symptoms of depression, which aligns with the target conditions of the clinical trial focused on depression in undergraduate college students. However, there is no mention of binge drinking, which is a key component of the trial's focus.",
            "relevance_score_R": 70.0,
            "eligibility_explanation": "The patient meets the inclusion criteria for being an undergraduate student and within the age range of 18-24. However, there is no information on binge drinking episodes, which is a crucial inclusion criterion. The patient shows symptoms of depression, but there is no direct evidence of a BDI-II score. The patient does not meet any exclusion criteria, as there is no mention of substance dependence (excluding alcohol), bulimia, psychosis, bipolar disorder, recent psychosocial treatment, CBT, pharmacological treatment, or severe depression. Overall, the lack of information on binge drinking significantly impacts eligibility.",
            "eligibility_score_E": 20.0
        },
        "NCT02633449": {
            "relevance_explanation": "The clinical trial is focused on treating major depression using a combination of cognitive behavioral therapy and tDCS. The patient exhibits several symptoms indicative of major depressive disorder, such as fatigue, increased sleep and appetite, difficulty concentrating, anhedonia, and guilt. However, there is no explicit diagnosis of unipolar major depressive disorder in the patient note. This makes the patient relevant to the trial, but not perfectly aligned due to the lack of a formal diagnosis.",
            "relevance_score_R": 70.0,
            "eligibility_explanation": "The patient shows symptoms consistent with major depressive disorder but lacks a formal diagnosis, which is required for inclusion. However, the patient does not meet any of the exclusion criteria, as there are no indications of other psychiatric or neurological conditions, no current medication, no history of manic or psychotic episodes, and no recent psychotherapy or electroconvulsive therapy. Therefore, the patient is not included by the inclusion criteria but is not excluded by any exclusion criteria.",
            "eligibility_score_E": 0.0
        }
    },
    "sigir-20158": {
        "NCT00393913": {
            "relevance_explanation": "The patient is a 10-year-old boy experiencing symptoms consistent with obstructive sleep apnea (OSA), such as nighttime snoring and excessive daytime sleepiness, which are directly relevant to the clinical trial's focus on sleep-disordered breathing and daytime alertness. The trial aims to study individuals with and without sleep apnea, and the patient's symptoms align with the target condition of the trial.",
            "relevance_score_R": 90.0,
            "eligibility_explanation": "The patient meets all the inclusion criteria, as he experiences symptoms of OSA and has a stable medical history. He is not excluded by any of the exclusion criteria, as there is no evidence of other sleep disorders, medically unstable conditions, use of psychotropic medications, recreational drug use, or communication impairments. Additionally, pregnancy is not applicable. Therefore, the patient is fully eligible for the trial.",
            "eligibility_score_E": 90.0
        },
        "NCT02562040": {
            "relevance_explanation": "The patient is a 10-year-old boy with symptoms of sleep-disordered breathing, such as nighttime snoring and pauses in breathing, which are relevant to the trial's focus on pediatric adenotonsillectomy for snoring. However, there is no formal diagnosis of mild sleep-disordered breathing (MSDB) or detailed information on the frequency and duration of snoring, which are important for the trial's inclusion criteria. The trial is specifically looking at children who snore but do not have obstructive sleep apnea, and the patient's symptoms align with this focus, making him relevant to the trial.",
            "relevance_score_R": 70.0,
            "eligibility_explanation": "The patient shows potential eligibility for the trial as he has nocturnal obstructive symptoms, which is a primary indication for adenotonsillectomy. However, there is insufficient information to confirm eligibility for most inclusion criteria, such as a formal diagnosis of MSDB, caregiver report of habitual snoring frequency, and results from a polysomnogram. The patient is not excluded by any of the exclusion criteria, which is positive for eligibility. Overall, the lack of detailed information on key inclusion criteria limits the eligibility score.",
            "eligibility_score_E": 20.0
        }
    },
    "sigir-20159": {
        "NCT01766830": {
            "relevance_explanation": "The clinical trial is focused on diagnosing tropical diseases in patients with persistent fever in specific countries. The patient is a 10-year-old child with a persistent fever for at least two weeks, which aligns with the trial's focus on persistent fever. However, the trial is geographically limited to Cambodia, Nepal, Democratic Republic of the Congo, and Sudan, and there is no indication that the patient is located in or has traveled to these regions. Despite this, the patient's symptoms and the focus on fever make them somewhat relevant to the trial's objectives.",
            "relevance_score_R": 50.0,
            "eligibility_explanation": "The patient meets the inclusion criteria of having a fever for more than one week and being over 5 years old. They are not excluded based on consent or compliance issues, nor is there an existing laboratory-confirmed diagnosis. However, the patient is experiencing respiratory distress, which suggests a need for immediate intensive care, leading to exclusion based on the trial's criteria. This significantly impacts the eligibility score.",
            "eligibility_score_E": -50.0
        }
    },
    "sigir-201510": {
        "NCT01377519": {
            "relevance_explanation": "The patient is a 38-year-old premenopausal woman experiencing severe menstrual symptoms, which are relevant to the trial targeting symptomatic uterine fibroids. The trial seeks premenopausal women with fibroid symptoms, making the patient a potentially relevant candidate.",
            "relevance_score_R": 85.0,
            "eligibility_explanation": "The patient meets several inclusion criteria: she is over 18, premenopausal, and has symptoms that could be associated with fibroids. However, there is insufficient information about the accessibility of fibroids for treatment. The patient is not excluded by most criteria, but she is excluded due to unexplained menstrual irregularity. This exclusion significantly impacts her eligibility.",
            "eligibility_score_E": -85.0
        },
        "NCT02340533": {
            "relevance_explanation": "The patient is a 38-year-old woman experiencing severe premenstrual and menstrual pelvic pain, heavy, irregular periods, and occasional spotting, which are symptoms associated with pelvic congestion. The clinical trial is focused on diagnosing adenomyosis, a condition that can cause such symptoms. Therefore, the patient's symptoms are highly relevant to the target condition of the trial.",
            "relevance_score_R": 90.0,
            "eligibility_explanation": "The patient meets the inclusion criterion as she is a female with symptoms of pelvic congestion, including dysmenorrhea, menorrhagia, and metrorrhagia. She is not excluded by the exclusion criterion, as she is willing to provide informed consent and comply with the trial protocol. Thus, the patient is eligible for the trial.",
            "eligibility_score_E": 90.0
        }
    },
    "sigir-201511": {
        "NCT01862510": {
            "relevance_explanation": "The clinical trial is focused on detecting celiac disease in patients with hypothyroidism. The patient exhibits symptoms suggestive of hypothyroidism, such as cold sensitivity, fatigue, hyporeflexia, and dry skin, which makes her relevant to the trial. However, there is no explicit mention of a hypothyroidism diagnosis or thyroid replacement therapy, which are key inclusion criteria for the trial. Therefore, the relevance is moderate.",
            "relevance_score_R": 60.0,
            "eligibility_explanation": "The patient shows symptoms suggestive of hypothyroidism but does not have a confirmed diagnosis or requirement for thyroid replacement therapy, which is necessary for inclusion. She does not meet the exclusion criteria, as there is no mention of prior treatments or procedures that would exclude her. However, without meeting the inclusion criteria, she is not eligible for the trial.",
            "eligibility_score_E": -60.0
        },
        "NCT01197183": {
            "relevance_explanation": "The patient exhibits symptoms consistent with hypothyroidism, such as sensitivity to cold, fatigue, constipation, hyporeflexia, and dry skin. These symptoms align with the target condition of the clinical trial, which is hypothyroidism. However, there is no explicit mention of a recent diagnosis of hypothyroidism, which is a key inclusion criterion. The patient is willing to provide informed consent, which is relevant to the trial's requirements.",
            "relevance_score_R": 70.0,
            "eligibility_explanation": "The patient meets the inclusion criterion of providing informed consent. However, the patient does not meet the inclusion criterion of having a recent diagnosis of hypothyroidism, which is crucial for eligibility. The patient is not excluded by any of the exclusion criteria, as there is no mention of recent participation in another clinical trial, no major risk of non-compliance, and no contraindications to L\u00e9vothyrox. Overall, the lack of a recent diagnosis of hypothyroidism significantly impacts eligibility.",
            "eligibility_score_E": 20.0
        }
    },
    "sigir-201512": {
        "NCT02418169": {
            "relevance_explanation": "The clinical trial is focused on the association between craniofacial fractures and brain injuries, specifically looking at skull fractures and traumatic brain injuries. The patient has a skull fracture from an automobile accident, which directly relates to the trial's target conditions. Although the patient note does not mention a craniofacial fracture or a GCS score, the presence of a skull fracture makes the patient relevant to the trial.",
            "relevance_score_R": 85.0,
            "eligibility_explanation": "The patient meets the inclusion criterion due to the presence of a skull fracture, which is part of the trial's focus. There is no exclusion criterion that applies to the patient, as he is alive and admitted to the hospital. Therefore, the patient is eligible for the trial based on the available information.",
            "eligibility_score_E": 85.0
        },
        "NCT02467309": {
            "relevance_explanation": "The clinical trial is focused on bacterial meningitis in children, while the patient is a 44-year-old man with symptoms that could suggest meningitis, such as fever and neck stiffness, following a skull fracture. However, there is no confirmation of bacterial meningitis through cerebrospinal fluid examination, and the trial is specifically for children, making the patient less relevant.",
            "relevance_score_R": 30.0,
            "eligibility_explanation": "The patient shows some symptoms that could be associated with bacterial meningitis, such as fever and neck stiffness, but lacks the necessary laboratory confirmation to meet the inclusion criteria. Additionally, the trial is for children, and the patient is an adult. The patient is not excluded by any of the exclusion criteria, but the lack of specific inclusion criteria fulfillment and age mismatch results in low eligibility.",
            "eligibility_score_E": -30.0
        }
    },
    "sigir-201513": {
        "NCT00315042": {
            "relevance_explanation": "The patient is a 5-year-old boy presenting with symptoms such as dysphagia, drooling, fever, and vocal changes. These symptoms are relevant to the clinical trial, which targets tonsillitis and pharyngitis in children aged 6 months to less than 13 years. However, there is no direct mention of Streptococcus pyogenes infection, which is a key inclusion criterion for the trial.",
            "relevance_score_R": 70.0,
            "eligibility_explanation": "The patient meets the age criterion and presents with symptoms that could be consistent with tonsillitis/pharyngitis, such as dysphagia and fever. However, there is no information about a positive rapid detection throat swab test for Group A streptococcal antigen, which is a crucial inclusion criterion. Additionally, the patient is excluded due to symptoms suggesting a possible deep tissue infection like epiglottitis. Therefore, the patient is not eligible for the trial.",
            "eligibility_score_E": -70.0
        },
        "NCT01255670": {
            "relevance_explanation": "The clinical trial is focused on the treatment of peritonsillar abscess in adult patients, while the patient is a 5-year-old boy with symptoms that could suggest a peritonsillar abscess but without a confirmed diagnosis. The trial is specifically for adults, which makes the patient less relevant. Additionally, the trial requires specific criteria such as language proficiency and email access, which are not addressed in the patient note.",
            "relevance_score_R": 20.0,
            "eligibility_explanation": "The patient is not eligible for the trial as the trial is for adults and the patient is a child. While the patient is voluntary, there is no confirmed diagnosis of peritonsillar abscess, and many criteria are not applicable or lack sufficient information. The patient is not excluded by any criteria, but the lack of inclusion in key criteria and the age mismatch make the patient ineligible.",
            "eligibility_score_E": -20.0
        }
    },
    "sigir-201514": {
        "NCT00827463": {
            "relevance_explanation": "The clinical trial is focused on early detection of anemia during the first trimester of pregnancy. The patient is a 27-year-old woman who is 11 weeks pregnant and has been diagnosed with anemia, which makes her relevant to the trial's target condition and timing. However, there is no information about whether she is being followed at the HME, which is a specific inclusion criterion.",
            "relevance_score_R": 80.0,
            "eligibility_explanation": "The patient is relevant to the trial as she is in the first trimester of pregnancy and has anemia. However, there is no information about her being followed at the HME, which is necessary for inclusion. She is not excluded based on language, beta thalassemia, or prior periconceptional treatment against anemia. Therefore, while she is not excluded, the lack of information about the inclusion criterion limits her eligibility.",
            "eligibility_score_E": 40.0
        },
        "NCT01308112": {
            "relevance_explanation": "The patient is a 27-year-old pregnant woman at 11 weeks gestation, which fits the inclusion criteria of being a woman aged 15-45 years and pregnant with gestational age less than 23 weeks. The trial is focused on prenatal iron supplementation, which is relevant given the patient's mild iron deficiency and current iron supplementation. However, the trial's primary focus is on malaria, and there is no mention of malaria in the patient's note, which slightly reduces the relevance.",
            "relevance_score_R": 80.0,
            "eligibility_explanation": "The patient meets the inclusion criteria of age and gestational age. However, she is excluded due to her initial hemoglobin concentration being exactly 90 g/L, which meets the exclusion criterion of being less than 90 g/L. She is not excluded by any other criteria. Therefore, while she is relevant to the trial, she is ineligible due to the hemoglobin level.",
            "eligibility_score_E": -80.0
        }
    },
    "sigir-201515": {
        "NCT01550588": {
            "relevance_explanation": "The patient is relevant to the trial as she has had a cryptogenic stroke within the last three months, which is a key inclusion criterion. However, the trial specifically targets patients with a high-risk Patent Foramen Ovale (PFO), which the patient does not have, as her echocardiogram found no abnormalities. This significantly reduces the relevance since the trial's main focus is on PFO-related stroke prevention.",
            "relevance_score_R": 50.0,
            "eligibility_explanation": "The patient meets several inclusion criteria: she had a cryptogenic stroke recently, is willing to participate in follow-up visits, and has no other potential causes of stroke identified. She is not excluded by any of the exclusion criteria. However, she does not meet the critical inclusion criterion of having a high-risk PFO, which is central to the trial. This makes her ineligible for the trial despite meeting other criteria.",
            "eligibility_score_E": -50.0
        },
        "NCT00932425": {
            "relevance_explanation": "The patient is a 72-year-old woman who recently experienced a cryptogenic stroke, which aligns with the target condition of the trial focused on stroke. The trial aims to study prolonged cardiac monitoring after cryptogenic stroke, and the patient has no history of atrial fibrillation, making her a potential candidate for detecting undiagnosed AF. However, there is no information confirming that the patient was seen at UCSF Medical Center, which is a specific requirement for the trial.",
            "relevance_score_R": 80.0,
            "eligibility_explanation": "The patient meets the age criterion and the criterion for recent onset of cryptogenic stroke. She is not excluded by any of the exclusion criteria, as there is no evidence of small-vessel disease, no source found on imaging, no history of atrial fibrillation, and she can provide informed consent. However, there is insufficient information to confirm if she was seen at UCSF Medical Center, which is a critical inclusion criterion. This lack of information prevents full eligibility.",
            "eligibility_score_E": 40.0
        }
    },
    "sigir-201516": {
        "NCT00930826": {
            "relevance_explanation": "The clinical trial is focused on childhood asthma, specifically bronchial asthma, and its impact on schooling. The patient is a 4-year-old boy presenting with wheezing, which could be related to asthma, but there is no clinical diagnosis of bronchial asthma mentioned in the patient note. The patient has a history of allergic rhinitis, which is related to respiratory issues, but not directly to asthma. Therefore, the relevance is moderate as the symptoms could suggest asthma, but there is no confirmed diagnosis.",
            "relevance_score_R": 50.0,
            "eligibility_explanation": "The patient does not meet the inclusion criterion of having a clinical diagnosis of bronchial asthma, which is crucial for eligibility. There is also not enough information to determine if the patient can swallow tablets, which is another inclusion criterion. However, the patient is not excluded based on the criterion of steroid use, as there is no mention of steroid inhalation or ingestion. Overall, the patient is not eligible due to the lack of a bronchial asthma diagnosis.",
            "eligibility_score_E": -50.0
        },
        "NCT00839124": {
            "relevance_explanation": "The clinical trial is focused on comparing individuals with allergic asthma to normal volunteers in response to an inhalational challenge. The patient is a 4-year-old boy with a history of allergic rhinitis and a recent episode of wheezing, but no history of asthma or wheezing after age 6, which is a key inclusion criterion. The trial is relevant to individuals with asthma or hypersensitivity, but the patient's age and lack of asthma history make him less relevant to the trial's target population.",
            "relevance_score_R": 30.0,
            "eligibility_explanation": "The patient does not meet the key inclusion criteria related to age and history of asthma, as he is only 4 years old and has no history of wheezing after age 6 or physician-diagnosed asthma after age 6. Additionally, there is insufficient information to assess eligibility for other inclusion criteria, such as lung function tests and allergy skin tests. However, the patient is not excluded by any of the exclusion criteria, as there is no evidence of chronic medical conditions, recent asthma exacerbations, or medication use that would disqualify him. Overall, the patient is not eligible due to not meeting the primary inclusion criteria.",
            "eligibility_score_E": -30.0
        },
        "NCT00711399": {
            "relevance_explanation": "The clinical trial is focused on assessing respiratory sounds, specifically cough and wheeze, which are directly relevant to the patient's current condition of wheezing and recent coughing. The patient is a 4-year-old boy with wheezing, which aligns with the trial's target condition of respiratory sounds. The trial aims to create a database of respiratory sounds, and the patient is experiencing relevant symptoms.",
            "relevance_score_R": 90.0,
            "eligibility_explanation": "The patient meets the inclusion criteria as informed consent can be provided by the parents/guardian, and the patient has symptoms of cough and wheeze. The patient does not meet any of the exclusion criteria: there are no chest tubes, no skin lesions, no respiratory distress, and the patient is not a pregnant woman. Therefore, the patient is fully eligible for the trial.",
            "eligibility_score_E": 90.0
        }
    },
    "sigir-201517": {
        "NCT01446198": {
            "relevance_explanation": "The clinical trial is focused on evaluating the APTIMA HPV Assay using the PANTHER System, which is relevant to patients with HPV infection. The patient in question has tested positive for HPV, making her condition relevant to the trial's target condition. However, the trial's specific criteria involve technical details about the sample and testing systems (APTIMA HPV Assay on TIGRIS System, availability of aliquots, random selection of samples) that are not addressed in the patient note. Therefore, while the patient's condition is relevant, the specific trial requirements are not directly mentioned.",
            "relevance_score_R": 60.0,
            "eligibility_explanation": "The patient is HPV positive, which aligns with the trial's target condition. However, the inclusion criteria require specific conditions related to the APTIMA HPV Assay on the TIGRIS System and sample handling, none of which are confirmed in the patient note. The patient is not included in any inclusion criteria due to lack of information and is not excluded by the exclusion criterion, which is not applicable. Therefore, the eligibility score is low due to insufficient information to confirm eligibility.",
            "eligibility_score_E": -30.0
        },
        "NCT01231945": {
            "relevance_explanation": "The clinical trial is focused on evaluating low-cost molecular tests for HPV in women who are at risk for cervical cancer. The patient is a 32-year-old female who has tested HPV positive, which makes her relevant to the trial as it targets women for cervical cancer screening. However, the trial specifically targets women living in rural China, which is not mentioned in the patient note. This geographical criterion affects the relevance score.",
            "relevance_score_R": 70.0,
            "eligibility_explanation": "The patient meets all the inclusion criteria: she has not been diagnosed with cervical cancer, has a cervix, is not pregnant, is physically able to undergo cervical cancer screening, and can provide informed consent. She is not excluded by any of the exclusion criteria, although there is no information about her menstrual status, which is a temporary exclusion. The main issue affecting eligibility is the geographical criterion, as the trial is for women in rural China, and there is no information indicating the patient meets this criterion.",
            "eligibility_score_E": 50.0
        }
    },
    "sigir-201518": {
        "NCT00149227": {
            "relevance_explanation": "The clinical trial is focused on patients with hypertension and other cardiovascular risk factors, including chronic heart failure. The patient exhibits symptoms consistent with chronic heart failure, such as shortness of breath, difficulty breathing when lying flat, lung crackles, ankle edema, and jugular venous distension. However, there is no mention of hypertension, which is a primary target condition of the trial. The patient is relevant to the trial due to the presence of chronic heart failure, but the lack of explicit mention of hypertension reduces the overall relevance.",
            "relevance_score_R": 70.0,
            "eligibility_explanation": "The patient meets one of the inclusion criteria due to symptoms consistent with chronic heart failure. The patient is not excluded by any of the exclusion criteria, as there is no information suggesting the presence of conditions that would lead to exclusion. However, the lack of a clinical diagnosis of hypertension, which is a key inclusion criterion, affects the eligibility. Therefore, the patient is partially eligible for the trial.",
            "eligibility_score_E": 35.0
        },
        "NCT00344513": {
            "relevance_explanation": "The patient exhibits symptoms consistent with heart failure, such as shortness of breath, difficulty breathing when lying flat, lung crackles, and edema. These symptoms align with the target condition of the clinical trial, which is heart failure. However, the patient note does not specify whether the patient is currently hospitalized or has been hospitalized due to these symptoms, which is a key aspect of the trial's inclusion criteria.",
            "relevance_score_R": 70.0,
            "eligibility_explanation": "The patient shows symptoms that are consistent with heart failure, which is relevant to the trial. However, there is insufficient information to determine eligibility because the patient note does not confirm hospitalization for heart failure or provide details on systolic or diastolic dysfunction. Therefore, the eligibility score is neutral.",
            "eligibility_score_E": 0.0
        },
        "NCT00534066": {
            "relevance_explanation": "The patient is a 65-year-old male presenting with symptoms and physical exam findings consistent with congestive heart failure (CHF), such as shortness of breath, difficulty breathing when lying flat, lung crackles, ankle edema, and jugular venous distension. These symptoms align with the target condition of the clinical trial, which is focused on patients with CHF in the Emergency Department. The patient is also able to provide informed consent and comply with the trial protocol. However, there is no explicit mention of hospital admission or transfer to the Observation Unit, which is a requirement for the trial.",
            "relevance_score_R": 85.0,
            "eligibility_explanation": "The patient meets the age criterion and presents with symptoms indicative of CHF, which aligns with the trial's inclusion criteria. The patient is not excluded based on the exclusion criteria, as there is no evidence of being a minor, prisoner, pregnant, unable to consent, having unstable angina or acute myocardial infarction, being dialysis dependent, or having received nesiritide therapy. However, there is insufficient information regarding the patient's admission to the hospital or transfer to the Observation Unit, which is necessary for full eligibility.",
            "eligibility_score_E": 70.0
        }
    },
    "sigir-201519": {
        "NCT02213809": {
            "relevance_explanation": "The clinical trial is focused on COPD, a condition that the patient is likely suffering from given her symptoms and significant smoking history. The trial aims to improve education for general practitioners on COPD management, which indirectly involves patients with COPD. However, the trial's primary focus is on healthcare providers rather than individual patients. The patient is relevant to the trial as a potential subject for the educational outcomes being measured, but the trial is not directly recruiting patients for treatment or intervention.",
            "relevance_score_R": 60.0,
            "eligibility_explanation": "The patient shows symptoms indicative of COPD, such as chronic cough and shortness of breath, and has a significant smoking history, which aligns with the trial's focus on COPD. However, there is no confirmed diagnosis of COPD or spirometry results indicating a GOLD grade of 2-3, which are required for patient inclusion in the trial. Therefore, the patient does not meet the specific inclusion criteria for the trial.",
            "eligibility_score_E": -60.0
        },
        "NCT02219360": {
            "relevance_explanation": "The patient is a 66-year-old female with a significant smoking history and symptoms consistent with chronic obstructive pulmonary disease (COPD), such as chronic cough and progressive shortness of breath. The clinical trial is focused on patients with acute exacerbation of COPD. However, the patient note does not mention hospitalization or an acute exacerbation, which are key components of the trial's inclusion criteria. Therefore, while the patient has COPD, the lack of information about an acute exacerbation and hospitalization reduces the relevance to the trial.",
            "relevance_score_R": 60.0,
            "eligibility_explanation": "The patient meets the age criterion (age \u2265 40 years) and is not excluded by any of the exclusion criteria, as there is no mention of conditions like congestive heart failure, lung cancer, or serious organ dysfunctions. However, the patient does not meet the primary inclusion criterion of being hospitalized with an acute exacerbation of COPD, which is crucial for eligibility. Therefore, the patient is not eligible for the trial.",
            "eligibility_score_E": -60.0
        },
        "NCT00806091": {
            "relevance_explanation": "The clinical trial is focused on studying COPD and the effects of smoking on the disease. The patient has a significant smoking history and presents with symptoms consistent with COPD, such as chronic cough and shortness of breath. This makes her highly relevant to the trial, as she fits the profile of a smoker with COPD, which is a key focus of the study.",
            "relevance_score_R": 90.0,
            "eligibility_explanation": "The patient meets the inclusion criterion of being a smoker with COPD, which is a primary focus of the trial. However, she does not meet the criterion for non-smokers with COPD. Since she is included in one of the key criteria and not excluded by any other criteria, she is eligible for the trial.",
            "eligibility_score_E": 90.0
        }
    },
    "sigir-201520": {
        "NCT00880347": {
            "relevance_explanation": "The clinical trial is focused on patients with Alzheimer's Disease (AD) and other types of dementia. The patient is an 89-year-old male with significant cognitive impairment and symptoms consistent with dementia, making him relevant to the trial's target conditions. However, there is no specific mention of a clinical diagnosis of probable AD or other specific types of dementia, which slightly reduces the relevance.",
            "relevance_score_R": 80.0,
            "eligibility_explanation": "The patient meets several inclusion criteria, such as age, ability to provide informed consent, and compliance with study procedures. However, the patient lacks a confirmed diagnosis of probable AD or specific dementia type, and there is no evidence of brain imaging to support such a diagnosis. Additionally, the presence of neurological signs like paratonic rigidity and myoclonic jerks may suggest other conditions, which affects eligibility. The patient is not excluded by any exclusion criteria, but the lack of specific diagnostic information and the presence of certain neurological signs prevent full eligibility.",
            "eligibility_score_E": 20.0
        },
        "NCT00182832": {
            "relevance_explanation": "The clinical trial is focused on older adults with cognitive impairment, which aligns with the patient's condition. The patient is 89 years old and exhibits significant cognitive impairment, making him relevant to the trial's target conditions. However, there is no explicit mention of the patient being hospitalized in a medical ward, which is a key aspect of the trial.",
            "relevance_score_R": 80.0,
            "eligibility_explanation": "The patient meets several inclusion criteria: he is over 65 years old, can speak English, and has cognitive impairment. However, there is no information confirming his hospitalization in a medical ward, which is necessary for full eligibility. He is not excluded by any of the exclusion criteria. Therefore, while he is relevant, the lack of information about hospitalization affects his eligibility.",
            "eligibility_score_E": 60.0
        }
    },
    "sigir-201521": {
        "NCT01959048": {
            "relevance_explanation": "The clinical trial is focused on the treatment of severe Clostridium Difficile Associated Colitis (CDAD) using Fecal Microbiota Transplantation (FMT). The patient presents with symptoms of diarrhea, abdominal cramping, and flatulence, but these are likely due to giardiasis, as indicated by the presence of Giardia cysts in the stool smear. The patient does not have a confirmed diagnosis of severe CDAD, which is the primary condition targeted by the trial. Therefore, the relevance of the patient to this trial is low.",
            "relevance_score_R": 20.0,
            "eligibility_explanation": "The patient meets some general inclusion criteria such as age and ability to provide informed consent. However, the patient does not have a confirmed diagnosis of severe CDAD, which is a critical inclusion criterion for the trial. Additionally, the patient is excluded due to having another known etiology for diarrhea, likely giardiasis. Therefore, the patient is ineligible for the trial.",
            "eligibility_score_E": -20.0
        },
        "NCT02105714": {
            "relevance_explanation": "The clinical trial is focused on diagnosing neglected tropical diseases among patients with persistent digestive disorders. The patient presents with symptoms such as diarrhea and abdominal cramping, which are relevant to the trial's focus on digestive disorders. However, the trial specifically requires persistent symptoms lasting at least 2 weeks, and there is no information in the patient note indicating the duration of the symptoms. The patient is willing to provide informed consent, which is relevant to the trial's requirements.",
            "relevance_score_R": 60.0,
            "eligibility_explanation": "The patient meets the inclusion criterion for providing informed consent and does not meet any exclusion criteria. However, the patient does not meet the key inclusion criterion of having persistent diarrhea lasting at least 2 weeks, which is crucial for eligibility. Therefore, while the patient is not excluded, he is also not fully eligible due to the lack of information on symptom duration.",
            "eligibility_score_E": 10.0
        }
    },
    "sigir-201522": {
        "NCT02534727": {
            "relevance_explanation": "The patient is a 65-year-old male with a history of tuberculosis, which directly relates to the trial's focus on TB and NTM infections. The patient has ongoing symptoms of pulmonary TB, making him relevant to the study's objective of examining TB drug pharmacokinetics. The trial is designed for individuals with TB or NTM infections, and the patient fits this demographic.",
            "relevance_score_R": 85.0,
            "eligibility_explanation": "The patient meets several inclusion criteria: he is over 18, has a history of TB, shows ongoing symptoms of pulmonary TB, is likely able to produce sputum samples, and is willing to comply with the trial protocol, including providing blood samples and having samples stored. However, there is no information on whether the patient is currently taking anti-tuberculosis medicines or if there is suspected drug resistance, which are critical for full eligibility. The patient is not excluded based on the available exclusion criteria.",
            "eligibility_score_E": 50.0
        },
        "NCT01207128": {
            "relevance_explanation": "The patient is a 65-year-old male with a diagnosis consistent with aspergillosis, as indicated by the culture results showing an organism with septated, low-angle branching hyphae. This aligns with the target condition of the trial, which is invasive aspergillosis. The patient is also willing to provide informed consent and is of the appropriate age for the trial. However, the trial is specifically for patients with hematological cancer, and there is no mention of the patient having such a condition, which reduces the relevance.",
            "relevance_score_R": 70.0,
            "eligibility_explanation": "The patient meets several inclusion criteria: he is willing to provide informed consent and is over 18 years old. However, there is insufficient information regarding the Aspergillus GM index and antibiotic use, which are crucial for confirming eligibility. The patient is not excluded by any exclusion criteria, but the lack of information on the GM index and hematological cancer status prevents full eligibility. Therefore, the eligibility score is positive but not maximal.",
            "eligibility_score_E": 30.0
        }
    },
    "sigir-201523": {
        "NCT00084240": {
            "relevance_explanation": "The patient is an 18-year-old male presenting with symptoms that could suggest malaria, such as high fever and joint pain, after returning from Asia. This aligns with the trial's focus on treating uncomplicated, symptomatic falciparum malaria in Southeast Asia. However, there is no direct evidence of a positive blood smear for Plasmodium falciparum, which is crucial for relevance. The trial is highly relevant to patients with confirmed malaria, but the lack of confirmation in this case reduces relevance.",
            "relevance_score_R": 60.0,
            "eligibility_explanation": "The patient does not meet the inclusion criteria due to the lack of a confirmed positive blood smear for Plasmodium falciparum and no information on serum glucose or rapid diagnostic test results. Additionally, the patient is excluded due to having leukopenia and thrombocytopenia, which are known blood dyscrasias. While the patient is not excluded by some criteria, the lack of inclusion and the presence of exclusion factors result in ineligibility.",
            "eligibility_score_E": -60.0
        },
        "NCT02334514": {
            "relevance_explanation": "The patient presents with symptoms that partially overlap with those of influenza, such as sudden onset of high fever, headache, and joint pain. However, the absence of other common influenza symptoms like cough, sore throat, and runny nose reduces the relevance. Additionally, there is no information about a PCR test for influenza or indication for antiviral treatment, which are crucial for the trial. The patient is not immune compromised, not pregnant, and likely has not been treated with oseltamivir recently, which aligns with the exclusion criteria.",
            "relevance_score_R": 50.0,
            "eligibility_explanation": "The patient is not included in the trial based on the inclusion criteria due to the lack of a complete clinical presentation for influenza and no information on a positive PCR test or indication for antiviral treatment. However, the patient is not excluded based on the exclusion criteria, as he is not immune compromised, not pregnant, and likely has not been treated with oseltamivir recently. This results in a neutral eligibility score.",
            "eligibility_score_E": 0.0
        }
    },
    "sigir-201524": {
        "NCT00540072": {
            "relevance_explanation": "The clinical trial is focused on treating moderate to severe community-acquired acute bacterial pneumonia due to S. pneumoniae. The patient presents with symptoms consistent with pneumonia, such as productive cough, fever, and chest pain, and has auscultatory findings suggestive of pulmonary consolidation. These symptoms align with the target condition of the trial, making the patient relevant to the study.",
            "relevance_score_R": 85.0,
            "eligibility_explanation": "The patient meets several inclusion criteria, such as providing informed consent, being an adult male, exhibiting clinical symptoms of pneumonia, having a productive cough, and having a documented fever. However, there is no information about a new pulmonary infiltrate on chest radiograph, which is a key inclusion criterion. The patient is not excluded by any exclusion criteria based on the available information. The lack of information on some criteria, such as the need for hospitalization and certain lab results, prevents a full assessment of eligibility.",
            "eligibility_score_E": 60.0
        },
        "NCT00711399": {
            "relevance_explanation": "The clinical trial is focused on assessing respiratory sounds, specifically targeting conditions like cough and wheeze. The patient presents with a productive cough and wheezing, which are directly relevant to the trial's target conditions. Additionally, the patient is willing to provide informed consent and comply with the trial protocol, which aligns with the trial's requirements.",
            "relevance_score_R": 90.0,
            "eligibility_explanation": "The patient meets all the inclusion criteria: he has a cough and is willing to provide informed consent. He is not excluded by any of the exclusion criteria, as there is no mention of chest tubes, skin lesions, or respiratory distress, and he is not pregnant. Therefore, the patient is fully eligible for the trial.",
            "eligibility_score_E": 90.0
        }
    },
    "sigir-201525": {},
    "sigir-201526": {},
    "sigir-201527": {},
    "sigir-201528": {},
    "sigir-201529": {
        "NCT00315042": {
            "relevance_explanation": "The clinical trial is focused on children aged 6 months to less than 13 years with Streptococcus pyogenes tonsillitis/pharyngitis. The patient is a 4-year-old girl, which fits the age criterion. However, the patient's symptoms (fever, rash, red tongue, red eyes) do not align with tonsillitis/pharyngitis, and there is no mention of a positive strep test or other specific symptoms required for inclusion. The patient's symptoms suggest a different condition, possibly Kawasaki disease, which is not relevant to the trial's focus on streptococcal infections.",
            "relevance_score_R": 30.0,
            "eligibility_explanation": "The patient meets the age criterion but does not meet any other inclusion criteria related to the clinical diagnosis of tonsillitis/pharyngitis or the required positive strep test. Additionally, the patient's symptoms suggest a nonstreptococcal condition, which is an exclusion criterion. Therefore, the patient is not eligible for the trial.",
            "eligibility_score_E": -30.0
        }
    }
}